Interesting facts
2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole
This unique compound, known as a benzimidazole derivative, captures the interest of chemists due to its diverse biological activities and complex structure. Here are some engaging facts about this intriguing chemical:
- Structural Significance: The incorporation of the benzimidazole core is vital, as benzimidazoles are well-known for their roles as pharmaceuticals, including antifungal, antiparasitic, and anticancer agents.
- Biological Activity: Compounds like this one often exhibit a variety of biological properties that can be explored for medicinal uses. Research has shown that benzimidazole derivatives can bind to certain biological targets, potentially leading to novel therapeutic avenues.
- Functional Groups: The presence of the methoxypropoxy and methylpyridyl substituents introduces additional versatility, likely impacting the compound's solubility and reactivity. This allows for tailored modifications to suit specific applications.
- Synthesis Challenges: Creating such complex molecules can involve multiple synthetic steps, often requiring careful manipulation of reaction conditions to ensure desired outcomes and to minimize byproducts.
- Future Research: Ongoing studies may explore the use of this compound in drug development, particularly in designing novel agents that target specific diseases. Its unique chemical structure and potential for modification make it a compelling candidate for further investigation.
In summary, the compound 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole showcases the fascinating interplay between complex organic chemistry and biological activity, offering a glimpse into the potential for future medical breakthroughs.
Synonyms
rabeprazole
117976-89-3
Aciphex
Habeprazole
pariprazole
Eraloc
Pariets
rabeprazol
Rabeloc
CHEBI:8768
HSDB 7321
2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole
LY307640
2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
Rabeprazole (INN)
UNII-32828355LL
E-3810 (PPI)
2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
32828355LL
DTXSID3044122
2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole
LY-307640
RABEPRAZOLE [INN]
Rabeprazole [INN:BAN]
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-
2-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole
E3810
(R)-2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Eraloc (TN)
rabeprazolum
2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole
2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole
2-{[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl}-1H-benzimidazole
MFCD00868879
2--1H-benzimidazole
Rabeprazole (Standard)
LY 307640
RABEPRAZOLE [MI]
RABEPRAZOLE [HSDB]
RABEPRAZOLE [VANDF]
CHEMBL1219
SCHEMBL23336
RABEPRAZOLE [WHO-DD]
MLS001401446
BIDD:GT0019
GTPL7290
DTXCID1024122
HY-B0656R
A02BC04
YREYEVIYCVEVJK-UHFFFAOYSA-N
BDBM651963
HMS2052P03
HMS3394P03
BCP06638
HY-B0656
BDBM50070209
s4845
STL186112
US11903935, Compound IA-6
AKOS015895259
CCG-101158
DB01129
NC00408
PB21725
NCGC00159518-12
NCGC00388029-07
NCGC00388029-09
AS-34993
SMR000469174
SBI-0206867.P001
DB-020298
DS-002860
NS00006247
Q3515
C07864
D08463
SBI-0206867.0001
AB00698237-06
EN300-7404394
SR-01000763041
SR-01000763041-3
BRD-A39390670-236-04-0
BRD-A39390670-236-09-9
BRD-A39390670-236-10-7
BRD-A39390670-236-11-5
BRD-A39390670-236-12-3
(S)-2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
1H-benzimidazole,2-[(r)-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-
2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole
2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl] sulfinyl]-1H-benzimidazole
2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H-benzimidazole
2-{[(3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl)methyl]sulphinyl}-1H-benzimidazole
2-{4-(3-Methoxypropoxy)-3-methylpyridine-2-yl}methylsulfinyl-1H-benzimidazole
2[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H- benzimidazole(National Library of Medicine, SIS; ChemIDplus Record for Rabeprazole (117976-89-3) Available from, as of August 11, 2005: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp)
Solubility of 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole
The solubility of 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole (C17H19N3O3S) is influenced by several factors including its structural characteristics and intermolecular interactions. This compound is known to exhibit the following solubility features:
In conclusion, while this compound may demonstrate reasonable solubility in organic solvents, its solubility in aqueous solutions might be limited due to the hydrophobic nature of certain substituents. Overall, assessing the solubility characteristics can provide valuable insights into its behavior in various environments.